LOS ANGELES, Sept. 20, 2017 /PRNewswire/ -- ThermoLife International, LLC announced today that the United States Patent and
The Patent Office's recognition of the patentability of these patent claims will allow ThermoLife to continue its patent enforcement actions, including those that have been stayed as a result of reexaminations, including those against Hi-Tech Pharmaceuticals, Neogenis/HumanN, and MusclePharm. As stated by ThermoLife's owner, Ron Kramer, "ThermoLife consistently has believed that these patent claims were valid all along, and the outcome of the reexamination proceeding has now underscored this."
ThermoLife intends to vigorously enforce its intellectual property rights through litigation against any company that sells infringing products without a license. Although always willing to reach a fair resolution, ThermoLife will not tolerate infringement of its patents. Accordingly, ThermoLife's legal team will continue to contact the manufacturers, distributors, and retailers of infringing products and taking any necessary actions to protect its rights.
Companies wishing to inquire about licensing or sublicensing opportunities, or any manufacturers, distributors and retailers who would like to confirm whether a particular nitrate-containing product has a license from ThermoLife, should contact Ron Kramer of ThermoLife, at [email protected].
About ThermoLife International, LLC
Founded in 1998, ThermoLife is a world leader in patented ingredients and technology for use in dietary supplements, specializing in nitrate technology. ThermoLife has a global patent portfolio of 27 patents spanning more than 25 countries including more than 450 issued claims related to the use of nitrates in dietary supplements. ThermoLife collaborates with leading manufacturers in the sports nutrition and supplement industry to offer superior patent-protected products to end users. For more information about ThermoLife and its patents, please contact Ron Kramer of ThermoLife, at [email protected].
View original content:http://www.prnewswire.com/news-releases/uspto-confirms-patentability-of-us-patent-no-9180140-exclusively-licensed-by-thermolife-international-300523174.html
SOURCE ThermoLife International, LLC
Subscribe to our Free Newsletters!
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...
Hashimoto's thyroiditis is an autoimmune disorder of the thyroid causing hypothyroidism. Synthetic ...
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...View All